Observational studyEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2018

Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.

Giuseppe Mastrangelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.